Medical Device News Magazine

KA Imaging Announces New Funding for Its Activities

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

X-ray manufacturer KA Imaging announced today new funding for its activities. Both new investments focus on the Reveal™ 35C detector. In-Q-Tel, Inc. and INOVAIT are now part of the strong list of partners working with KA Imaging.

Spectral Imaging in the Emergency Department

One of the projects, “Single exposure Dual Energy Subtraction X-ray Device for Image Guided Therapy”, aims to use the Reveal 35C in the Emergency Room. KA Imaging, in partnership with Sunnybrook Research Institute, will obtain X-ray images from patients, and use it to develop new material separation imaging algorithms for real-time image-guided therapy applications.

Funding for this project was provided in part by INOVAIT through the Government of Canada’s Strategic Innovation Fund.

“We’re proposing a widely accessible and affordable solution to achieve improved soft tissue, bone and foreign object visibility, without added acquisition time or patient imaging dose,” explained Karim S. Karim, CTO of KA Imaging.

INOVAIT is a pan-Canadian network funded by the Government of Canada and hosted at the Sunnybrook Research Institute with the objective of building a truly integrated image-guided therapy ecosystem, fueling continuous innovation that revolutionizes healthcare globally. Through connecting, educating, and investing in the industry’s brightest minds and most promising ventures, INOVAIT will support and encourage collaborative development and the integration of artificial intelligence (AI) into medical technologies.

Accelerating innovation

KA Imaging has also signed a strategic investment and technology development agreement with In-Q-Tel, the not-for-profit strategic investor that accelerates the development and delivery of cutting-edge technologies to the U.S. intelligence and national security community and its allies.

“KA Imaging’s patented technology benefits application areas ranging from healthcare to non-destructive testing. Reveal’s unique energy subtraction capabilities and portability make it a solution that can be effectively and easily deployed in challenging environments,” said Michael Falcon, Investment Partner at In-Q-Tel.

“We are pleased to be part of the In-Q-Tel portfolio and look forward to expanding our relationship with IQT and its government partners”, said Amol Karnick, President and CEO of KA Imaging.

About Reveal 35C

Reveal™ 35C is a single exposure, portable, digital dual-energy subtraction (DES) X-ray detector. Powered by its exclusive SpectralDR™technology, it uses the same radiation dose as a traditional X-ray to create 3 different images without motion artifacts. In medical applications, this means a regular DR, plus a soft tissue and bone images. In the NDT market, Reveal’s energy subtraction capabilities can be translated into material differentiation, such as metals and plastics.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”